Profile | GDS4284 / 217748_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 6175.59 | 95 |
GSM687648 | Patient 402 control | 9058.17 | 97 |
GSM687653 | Patient 403 control | 2898.58 | 88 |
GSM687658 | Patient 404 control | 6107.89 | 95 |
GSM687663 | Patient 411 control | 9654.43 | 97 |
GSM687668 | Patient 422 control | 8670.38 | 96 |
GSM687673 | Patient 424 control | 17676.7 | 99 |
GSM687678 | Patient 425 control | 8002.99 | 96 |
GSM687683 | Patient 427 control | 10922.6 | 98 |
GSM687688 | Patient 428 control | 3716.56 | 91 |
GSM687695 | Patient 441 control | 71399.6 | 99 |
GSM687699 | Patient 443 control | 11478 | 97 |
GSM687704 | Patient 444 control | 6153.77 | 95 |
GSM687707 | Patient 448 control | 4648.7 | 93 |
GSM687712 | Patient 449 control | 8893.81 | 97 |
GSM687719 | Patient 450 control | 18023.5 | 99 |
GSM687724 | Patient 451 control | 14057.4 | 98 |
GSM687728 | Patient 452 control | 10076.5 | 97 |
GSM687646 | Patient 401 treated 24h | 4224.64 | 92 |
GSM687649 | Patient 402 treated 24h | 8928.05 | 97 |
GSM687665 | Patient 411 treated 24h | 11368.9 | 98 |
GSM687651 | Patient 402 treated 4 weeks | 10450.6 | 97 |
GSM687667 | Patient 411 treated 4 weeks | 6005.71 | 95 |
GSM687670 | Patient 422 treated 24h | 8683.55 | 97 |
GSM687671 | Patient 422 treated 4 weeks | 9046.25 | 97 |
GSM687654 | Patient 403 treated 24h | 3626.57 | 90 |
GSM687675 | Patient 424 treated 24h | 19578.2 | 99 |
GSM687685 | Patient 427 treated 24h | 10096.3 | 97 |
GSM687656 | Patient 403 treated 4 weeks | 5009.65 | 93 |
GSM687677 | Patient 424 treated 4 weeks | 7444.84 | 96 |
GSM687687 | Patient 427 treated 4 weeks | 3664.77 | 91 |
GSM687692 | Patient 428 treated 4h | 3820.58 | 91 |
GSM687716 | Patient 449 treated 4h | 3655.65 | 91 |
GSM687722 | Patient 450 treated 4h | 19414.5 | 99 |
GSM687680 | Patient 425 treated 24h | 8878.56 | 97 |
GSM687690 | Patient 428 treated 24h | 4467.6 | 92 |
GSM687700 | Patient 443 treated 24h | 26755 | 99 |
GSM687705 | Patient 444 treated 24h | 4450.51 | 92 |
GSM687714 | Patient 449 treated 24h | 7933.85 | 96 |
GSM687721 | Patient 450 treated 24h | 39826.8 | 99 |
GSM687682 | Patient 425 treated 4 weeks | 5311.38 | 94 |
GSM687694 | Patient 428 treated 4 weeks | 5716.92 | 94 |
GSM687702 | Patient 443 treated 4 weeks | 12181.2 | 98 |
GSM687718 | Patient 449 treated 4 weeks | 3763.69 | 91 |
GSM687723 | Patient 450 treated 4 weeks | 14173.3 | 98 |
GSM687661 | Patient 404 treated 4h | 7317.4 | 96 |
GSM687710 | Patient 448 treated 4h | 8570.21 | 96 |
GSM687726 | Patient 451 treated 4h | 16586.3 | 98 |
GSM687730 | Patient 452 treated 4h | 6807.1 | 96 |
GSM687660 | Patient 404 treated 24h | 26250.6 | 99 |
GSM687697 | Patient 441 treated 24h | 29254.1 | 99 |
GSM687709 | Patient 448 treated 24h | 6535.84 | 95 |
GSM687725 | Patient 451 treated 24h | 20907.8 | 99 |
GSM687729 | Patient 452 treated 24h | 33389.8 | 99 |
GSM687727 | Patient 451 treated 4 weeks | 11301.7 | 98 |
GSM687731 | Patient 452 treated 4 weeks | 9698.52 | 97 |